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In conclusion, S. boydii should be considered among the rare
but possible causes of vertebral osteomyelitis.
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Outer Retinal Necrosis Due to a Strain of Varicella-
Zoster Virus Resistant to Acyclovir, Ganciclovir, and
Sorivudine
Theinhibitory activityof acycloviris basedon itsphosphorylation
by theviralthymidine kinase(TK).AfterpatientswithAIDSreceive
long-termtreatmentwith acyclovirfor the controlof infections with
herpes zoster and herpes simplex viruses, resistant isolates may
appear. Most of the resistant strains are either deficient in TK or
inducea TK withan alteredsubstratespecificity [I, 2]. Foscarnethas
a differentinhibitionmechanismand is the established alternative in
these cases [3]. However, its toxicity and the need for intravenous
administration are drawbacks. Sorivudine is one of the most active
compounds against varicella-zoster virus (VZV) [4] and has favor-
able pharmacokinetics permitting once-daily administration. How-
ever, as its inhibitory mechanism is also based on the phosphoryla-
tion by the viral enzyme,strainswith an alteredTK [I, 5] may have
reduced susceptibility to sorivudine as well.
Disseminated necrotic skin lesions developed in May 1994 in a
38-year-old woman with AIDS. These lesions diminished but never
disappeared completely, despite the administration of high doses of
oral acyclovir (5 X 800 mg/d), On 21 October outer retinal necrosis
occurred in herrighteye.Treatment withfoscarnet (10g/d)wasstarted
on 23 October. The skin lesions healedbut she lostvision in her right
eye, and the retinawas completely detached by 26 October.
On 7 November treatment with foscamet was interrupted be-
cause of renal failure, and treatment with sorivudine was started
at reduced dosages of 40 mg every 2 days (usual dose, 40 rng/d).
Skin lesions did not recur during therapy with sorivudine. How-
ever, retinal lesions appeared in her left eye on 8 December.Treat-
ment with foscamet was started again, combined with intravitreal
administration of ganciclovir (200 f-Lg twice weekly). The retinal
lesions responded, but her vision decreased on 24 January 1995
and progressed to blindness on 27 January. Treatment with sori-
vudine was discontinued on II January because of thrombocyto-
penia (nadir 10,000 platelets/ul.), and foscamet was withdrawn
on 8 February. The patient died on 15 March.
Before treatment with foscarnet was started, VZV was isolated
from CSF obtained by a lumbar puncture (21 October 1994); the
virus was grown on fibroblasts. No other viruses were detected at
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Table 1. Susceptibility of theVZVisolate to various antiviral drugs.
Susceptibility
(inhibitory concentration of 50% [J.lM])
Virus Susceptible
Drug isolate control Cutoff
Acyclovir 215 6.3 10
Ganciclovir 24.5 3.3 5
BV-ARA-U* 4.7 0.003 <0.01
Foscarnet 211 200 250
NOTE. Human foreskin fibroblasts were seeded in 12-well plates. VZV-
infected cells were seeded at a concentration that yielded 50-100 plaques per
well and were incubated in the presence of antiviral drugs. After 4 days of
incubation, plates were fixed and stained with Wright-Giemsa.
* [1-.B-o-arabinofuranosyl-E-5[2-bromovinyl] uracil.
that time in bronchoalveolarlavage fluid, blood, saliva, throat swab
specimens, or urine.
In addition,nested PCR revealedVZV DNA in anteriorchamber
fluid. PCR for cytomegalovirus, herpes simplex virus, and Tox-
oplasma gondii was negative. In each reaction with material from
the patient, two H20 samples were included as a negative control;
a positivecontrolwas includedas well. Primers from the following
genomic regions were used: the membrane glycoprotein gpIl re-
gion for VZV; the IE region for cytomegalovirus, the gene region
of UL42 for herpes simplex virus, and the B, gene repeat for
T. gondii. In addition, 10 f-LL of the extracted DNA was used to
amplify the TNF-a gene in a single-round peR. The product of
the inner PCR was checked for size on an agarose gel.
The VZV isolate replicated rapidly in cell culture, and the plaque
reduction assay revealed resistance against acyclovir, ganciclovir, and
BV-ARA-U (defined in table 1), although the patient had neverbeen
treated withBV-ARA-U before. Theviruswassusceptible to foscarnet.
Long-term administration of acyclovir to this patient with AIDS
selected multiresistant VZV, which was also resistant to the potent
VZV inhibitor sorivudine. This multiresistance was probably due to
an altered or lacking TK and leftonlyfoscamet as a treatment option,
although this approach was seriously hampered by renaltoxicity. This
observation demonstrates the need for alternative nontoxic antiviral
drugs with different mechanisms than the inhibition of TK.
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Age Distribution Among Patients at High Risk for
Human T-Cell Lymphotrophic Virus Type I Infection
Human T-celllymphotropic virus type I (HTLV-I) is a human
retrovirus associated with adult T cell leukemia and tropical
spastic paraparesis. We recently reported a high incidence of
HTLV-I infection in Israeli Jews originating from the city of
Mashhad in Iran [1, 2]. There is a characteristic age-dependent
increase in the seroprevalence of HTLV-I infection in areas of
endemicity. This increase typically occurs in adulthood and is
higher in females than in males throughout their lifetimes [3,
4]. It is not fully understood whether age, immunity, and the
CNS are distinctive factors or cofactors associated with morbid-
ity in elderly populations. We designed the present study to
investigate whether there is an age-dependent increase in the
incidence of HTLV-I infection in a population at high risk; the
results of our investigation were designed to be used as a model
for CNS infectivity in the elderly.
The Jews of Mashhad were persecuted because of their religious
beliefs since 1747, but they secretly continued to practice the
Jewish religion and to intermarry, resulting in families that are
closely related genetically. We included 321 Iranian Jews of Mash-
hadi origin (either the subject or at least one of his or her parents
was born in Mashhad) in our study. All subjects underwent physi-
cal and neurological examination, and samples of peripheral blood
were obtained from each subject after informed consent was ob-
tained. Sera were tested for antibodies to HTLV-I with use of the
gelatin-particle agglutination test, and genomic DNA was ampli-
fied as previously reported [2]. Statistical analysis was performed
with analysis of variance (ANOVA).
Of the 321 subjects included in the study, 203 were female
and 118 were male (mean age z SD, 45.7::':: 22.3 years). Fifty-
eight (18%) of the 321 subjects (38 females and 20 males; mean
age z SD, 50::':: 17.3 years) were positive for HTLV-I antibody
by serological testing and by peR analysis. Of the 58 HTLV-I
infected subjects, 36 were asymptomatic carriers, whereas 22
(14 females and 8 men; 38%) had signs of spastic paraparesis.
None of the 263 subjects who were not infected had abnormali-
ties of the pyramidal tract compatible with spastic paraparesis.
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Figure 1. Age-related distribution of HTLV-I infectivity in the
MashhadiJewish population. The numberof individualsin the Mash-
hadi Jewishpopulationis representedby •. The percentageof HTLV-
I infected individualsby age group is represented by 1:,..
The age distribution among the various decades ofthe Mashhadi
population being studied is presented in figure 1. The age distribu-
tion of HTLV-I-infected subjects was significantly different from
that of the healthy Mashhadi population (P < .01); in addition,
the incidence of infection was distributed in a bimodal pattern,
with a peak in the incidence of infection in young adulthood (20-
30 years old) and a gradual rise reaching a second peak in the
incidence of infection in the very elderly (80-90 years old).
The HTLV-I infection rate (18%) in the Mashhadi population
in the present study is similar to that found in our previous studies
[1,2]. The most striking finding in the present study was the high
rate of infection among the elderly population (>60 years old).
This finding is an extension of the reported clustering of HTLV-
I infection within a nursing home for Mashhadi elderly [1]. HTLV-
I is known to be transmitted by sexual intercourse [5], from mother
to child in breast milk [6], via blood transfusion [7], and by sharing
of needles by parenteral drug abusers [8]. These modes of transmis-
sion can account for the early peak of HTLV-I infection in the
younger population. However, the increase in the incidence of
HTLV-I infection in the elderly is poorly understood since trans-
